{"schema_version":"1.0","type":"article","title":"Obesity Becomes King: How GLP-1 Is Reshuffling Global Biotech Capital","url":"https://drugnews.com.tw/articles/2026-06-11-glp1-biotech-capital-reshuffle-en.html","markdown_url":"https://drugnews.com.tw/articles/2026-06-11-glp1-biotech-capital-reshuffle-en.md","lang":"en","date":"2026-06-11","publish_at":"2026-06-11T08:00:01+08:00","updated_at":"2026-06-11","category":"商業分析系列","topic":"生技估值","tags":["Biotech Valuation","Obesity medicine","Business development","Capital markets","Biotech business analysis","Drug development"],"summary":"GLP-1 is no longer only a weight-loss topic. It is redirecting biotech capital, BD urgency, manufacturing attention, and valuation imagination across global pharma.","key_points":[],"facts":[],"sections":[],"references":[],"images":[{"alt":"Capital Is Moving","url":"https://drugnews.com.tw/assets/articles/glp1-biotech-capital-reshuffle-en/figure-01.png"},{"alt":"From Drug to Ecosystem","url":"https://drugnews.com.tw/assets/articles/glp1-biotech-capital-reshuffle-en/figure-02.png"},{"alt":"BD Repricing","url":"https://drugnews.com.tw/assets/articles/glp1-biotech-capital-reshuffle-en/figure-03.png"},{"alt":"Investor Question","url":"https://drugnews.com.tw/assets/articles/glp1-biotech-capital-reshuffle-en/figure-04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/glp1-biotech-capital-reshuffle-en/cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-06-11）。Obesity Becomes King: How GLP-1 Is Reshuffling Global Biotech Capital。https://drugnews.com.tw/articles/2026-06-11-glp1-biotech-capital-reshuffle-en.html","disclaimer":"This article is intended for industry research and knowledge sharing only. It does not constitute investment, medical, fundraising, or individual stock advice.","translations":{"zh-Hant":"2026-06-11-glp1-biotech-capital-reshuffle.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}